<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8613707" created="07/07/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8613707</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Transcriptional basis for hyporesponsiveness of the <term id="T1" lex="human_inducible_nitric_oxide_synthase_gene" sem="DNA_domain_or_region">human inducible <term id="T2" lex="nitric_oxide_synthase_gene" sem="DNA_domain_or_region">nitric oxide synthase gene</term></term> to <term id="A1" sem="Lipid">lipopolysaccharide</term>/<term id="A2" sem="Protein_molecule">interferon-gamma</term>.</sentence>
<event KT="Other" id="E1">
<type class="Regulation"/>
<theme idref="T2"/>
<cause idref="A1"/>
<clue>Transcriptional basis for <clueType>hyporesponsiveness</clueType> <linkTheme>of</linkTheme> the human inducible nitric oxide synthase gene <linkCause>to</linkCause> lipopolysaccharide/interferon-gamma.</clue>
</event>
<event KT="Other" id="E2">
<type class="Regulation"/>
<theme idref="T2"/>
<cause idref="A2"/>
<clue>Transcriptional basis for <clueType>hyporesponsiveness</clueType> <linkTheme>of</linkTheme> the human inducible nitric oxide synthase gene <linkCause>to</linkCause> lipopolysaccharide/interferon-gamma.</clue>
</event>
<event KT="Other" id="E30">
<type class="Negative_regulation"/>
<theme idref="E1"/>
<clue>Transcriptional basis for <clueType>hyporesponsiveness</clueType> of the human inducible nitric oxide synthase gene to lipopolysaccharide/interferon-gamma.</clue>
<comment>CAUTION: hypo</comment></event>
<event KT="Other" id="E31">
<type class="Negative_regulation"/>
<theme idref="E2"/>
<clue>Transcriptional basis for <clueType>hyporesponsiveness</clueType> of the human inducible nitric oxide synthase gene to lipopolysaccharide/interferon-gamma.</clue>
<comment>CAUTION: hypo</comment></event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The work reported here resolves, at the level of gene regulation, the controversy as to whether or not <term id="T3" lex="human_monocytes/macrophage" sem="Cell_natural">human <term id="T4" lex="monocyte" sem="Cell_natural">monocytes</term>/<term id="A20" sem="Cell_natural">macrophages</term></term> can produce <term id="T5" lex="nitric_oxide" sem="Inorganic_compound">nitric oxide</term> (<term id="T6" lex="NO" sem="Inorganic_compound">NO</term>) when stimulated with <term id="T7" lex="lipopolysaccharide" sem="Lipid">lipopolysaccharide</term> (<term id="T8" lex="LPS" sem="Lipid">LPS</term>), with or without co-stimulation by interferon-gamma (<term id="T9" lex="IFN-gamma" sem="Protein_molecule">IFN-gamma</term>).</sentence>
<event KT="Other" id="E171">
<type class="Physiological_process"/>
<theme idref="T3"/>
<cause idref="T8"/>
<clue>The work reported here resolves, at the level of gene regulation, the controversy as to whether or not human monocytes/macrophages can produce nitric oxide (NO) when <clueType>stimulated</clueType> <linkTheme>with</linkTheme> lipopolysaccharide (LPS), with or without co-stimulation by interferon-gamma (IFN-gamma).</clue>
</event>
<event KT="Other" id="E172">
<type class="Physiological_process"/>
<theme idref="A20"/>
<cause idref="T8"/>
<clue>The work reported here resolves, at the level of gene regulation, the controversy as to whether or not human monocytes/macrophages can produce nitric oxide (NO) when <clueType>stimulated</clueType> <linkTheme>with</linkTheme> lipopolysaccharide (LPS), with or without co-stimulation by interferon-gamma (IFN-gamma).</clue>
</event>
<event KT="Other" id="E173">
<type class="Physiological_process"/>
<theme idref="T3"/>
<cause idref="T9"/>
<clue>The work reported here resolves, at the level of gene regulation, the controversy as to whether or not human monocytes/macrophages can produce nitric oxide (NO) when stimulated with lipopolysaccharide (LPS), with or without <clueType>co-stimulation</clueType> <linkTheme>by</linkTheme> interferon-gamma (IFN-gamma).</clue>
</event>
<event KT="Other" id="E174">
<type class="Physiological_process"/>
<theme idref="A20"/>
<cause idref="T9"/>
<clue>The work reported here resolves, at the level of gene regulation, the controversy as to whether or not human monocytes/macrophages can produce nitric oxide (NO) when stimulated with lipopolysaccharide (LPS), with or without <clueType>co-stimulation</clueType> <linkTheme>by</linkTheme> interferon-gamma (IFN-gamma).</clue>
</event>
<event KT="Investigation" id="E175" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="T6"/>
<cause idref="E171"/>
<clue>The work reported here resolves, at the level of gene regulation, the controversy as to <clueKT>whether or not</clueKT> human monocytes/macrophages can <clueType>produce</clueType> nitric oxide (NO) <linkCause>when</linkCause> stimulated with lipopolysaccharide (LPS), with or without co-stimulation by interferon-gamma (IFN-gamma).</clue>
</event>
<event KT="Investigation" id="E176" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="T6"/>
<cause idref="E172"/>
<clue>The work reported here resolves, at the level of gene regulation, the controversy as to <clueKT>whether or not</clueKT> human monocytes/macrophages can <clueType>produce</clueType> nitric oxide (NO) <linkCause>when</linkCause> stimulated with lipopolysaccharide (LPS), with or without co-stimulation by interferon-gamma (IFN-gamma).</clue>
</event>
<event KT="Investigation" id="E177" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="T6"/>
<cause idref="E171"/>
<cause idref="E173"/>
<clue>The work reported here resolves, at the level of gene regulation, the controversy as to <clueKT>whether or not</clueKT> human monocytes/macrophages can <clueType>produce</clueType> nitric oxide (NO) when stimulated with lipopolysaccharide (LPS), <linkCause>with</linkCause> or without co-stimulation by interferon-gamma (IFN-gamma).</clue>
</event>
<event KT="Investigation" id="E178" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="T6"/>
<cause idref="E172"/>
<cause idref="E174"/>
<clue>The work reported here resolves, at the level of gene regulation, the controversy as to <clueKT>whether or not</clueKT> human monocytes/macrophages can <clueType>produce</clueType> nitric oxide (NO) when stimulated with lipopolysaccharide (LPS), <linkCause>with</linkCause> or without co-stimulation by interferon-gamma (IFN-gamma).</clue>
</event>
<sentence id="S3">Studies included structural comparison of the promoters for <term id="T10" lex="human" sem="Multicellular_organism_natural">human</term> and <term id="T11" lex="mouse" sem="Multicellular_organism_natural">mouse</term> <term id="T12" lex="inducible_NO_synthase_(iNOS)_gene" sem="DNA_family_or_group"><term id="T13" lex="inducible_NO_synthase" sem="Protein_molecule">inducible <term id="T14" lex="NO" sem="Inorganic_compound">NO</term> synthase</term> (<term id="T15" lex="iNOS" sem="Protein_molecule">iNOS</term>) genes</term>, <term id="T16" lex="transfection_and_assay" sem="Other">transfection and assay</term> of human and mouse <term id="T17" lex="iNOS_promoter_region" sem="DNA_domain_or_region"><term id="T18" lex="iNOS" sem="Protein_molecule">iNOS</term> promoter regions</term> in response to <term id="T19" lex="LPS" sem="Lipid">LPS</term> +/- <term id="T20" lex="IFN-gamma" sem="Protein_molecule">IFN-gamma</term>, and <term id="T21" lex="electrophoretic_mobility_shift_assay" sem="Other">electrophoretic mobility shift assays</term> of <term id="T22" lex="kappa_B_response_element" sem="DNA_domain_or_region">kappa B response elements</term>.</sentence>
<event KT="Other" id="E5" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="T17"/>
<cause idref="T19"/>
<clue>Studies included structural comparison of the promoters for human and mouse inducible NO synthase (iNOS) genes, transfection and assay of human and mouse iNOS promoter regions in <clueType>response</clueType> <linkCause>to</linkCause> LPS +/- IFN-gamma, and electrophoretic mobility shift assays of kappa B response elements.</clue>
</event>
<event KT="Other" id="E6" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="T17"/>
<cause idref="T19"/>
<cause idref="T20"/>
<clue>Studies included structural comparison of the promoters for human and mouse inducible NO synthase (iNOS) genes, transfection and assay of human and mouse iNOS promoter regions in <clueType>response</clueType> <linkCause>to</linkCause> LPS +/- IFN-gamma, and electrophoretic mobility shift assays of kappa B response elements.</clue>
</event>
<sentence id="S4">Two explanations for hyporesponsiveness of the <term id="T23" lex="human_iNOS_promoter" sem="DNA_domain_or_region">human <term id="T24" lex="iNOS" sem="Protein_molecule">iNOS</term> promoter</term> to <term id="T25" lex="LPS" sem="Lipid">LPS</term> +/- <term id="T26" lex="IFN-gamma" sem="Protein_molecule">IFN-gamma</term> were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the <term id="T27" lex="enhancer_element" sem="DNA_domain_or_region">enhancer element</term> that has been shown to regulate <term id="T28" lex="LPS" sem="Lipid">LPS</term>/<term id="T29" lex="IFN-gamma_induced_expression" sem="Other"><term id="T30" lex="IFN-gamma" sem="Protein_molecule">IFN-gamma</term> induced expression</term> of the <term id="T31" lex="mouse_iNOS_gene" sem="DNA_domain_or_region">mouse <term id="T32" lex="iNOS" sem="Protein_molecule">iNOS</term> gene</term>; and (2) and absence of one or more <term id="T33" lex="nuclear_factor" sem="Protein_family_or_group">nuclear factors</term> in <term id="T34" lex="human_macrophage" sem="Cell_natural">human macrophages</term> (e.g., an <term id="T35" lex="LPS-inducible_nuclear_factor-kappa_B/Rel_complex" sem="Protein_complex"><term id="T36" lex="LPS" sem="Lipid">LPS</term>-inducible nuclear factor-kappa B/<term id="T37" lex="Rel" sem="Protein_family_or_group">Rel</term> complex</term>), that is (are) required for maximal expression of the gene.</sentence>
<event KT="Other" id="E7">
<type class="Regulation"/>
<theme idref="T23"/>
<cause idref="T25"/>
<clue>Two explanations for <clueType>hyporesponsiveness</clueType> <linkTheme>of</linkTheme> the human iNOS promoter <linkCause>to</linkCause> LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event KT="Other" id="E8">
<type class="Regulation"/>
<theme idref="T23"/>
<cause idref="T25"/>
<cause idref="T26"/>
<clue>Two explanations for <clueType>hyporesponsiveness</clueType> <linkTheme>of</linkTheme> the human iNOS promoter <linkCause>to</linkCause> LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event KT="Other" Manner="Low" id="E9">
<type class="Negative_regulation"/>
<theme idref="E7"/>
<clue>Two explanations for <clueType><clueManner>hypo</clueManner>responsiveness</clueType> of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
<comment>CAUTION: hypo</comment></event>
<event KT="Other" Manner="Low" id="E10">
<type class="Negative_regulation"/>
<theme idref="E8"/>
<clue>Two explanations for <clueType><clueManner>hypo</clueManner>responsiveness</clueType> of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
<comment>CAUTION: hypo</comment></event>
<event KT="Other" id="E11">
<type class="Mutagenesis"/>
<theme idref="T27"/>
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating <clueType>nucleotide substitutions</clueType> <linkTheme>in</linkTheme> the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event KT="Other" id="E12">
<type class="Gene_expression"/>
<theme idref="T31"/>
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced <clueType>expression</clueType> <linkTheme>of</linkTheme> the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event KT="Other" id="E61">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<cause idref="T28"/>
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma <clueType>induced</clueType> expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event KT="Other" id="E62">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<cause idref="T30"/>
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma <clueType>induced</clueType> expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event KT="Analysis" Source="Other" id="E13">
<type class="Negative_regulation"/>
<theme idref="E61"/>
<cause idref="E11"/>
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple <clueType>inactivating</clueType> nucleotide substitutions in the human counterpart of the enhancer element that <clueSource>has been</clueSource> <clueKT>shown</clueKT> to <clueType>regulate</clueType> LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event KT="Analysis" Source="Other" id="E81">
<type class="Negative_regulation"/>
<theme idref="E62"/>
<cause idref="E11"/>
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple <clueType>inactivating</clueType> nucleotide substitutions in the human counterpart of the enhancer element that <clueSource>has been</clueSource> <clueKT>shown</clueKT> to <clueType>regulate</clueType> LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event KT="Other" id="E14">
<type class="Negative_regulation"/>
<theme idref="T33"/>
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and <clueType>absence</clueType> <linkTheme>of</linkTheme> one or more nuclear factors <clueLoc>in human macrophages</clueLoc> (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event KT="Other" id="E82">
<type class="Negative_regulation"/>
<theme idref="T35"/>
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and <clueType>absence</clueType> <linkTheme>of</linkTheme> one or more <corefTheme>nuclear factors</corefTheme> <clueLoc>in human macrophages</clueLoc> (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event KT="Other" Manner="High" id="E15">
<type class="Gene_expression"/>
<theme idref="T31"/>
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for <clueManner>maximal</clueManner> <clueType>expression</clueType> <linkTheme>of</linkTheme> <corefTheme>the gene</corefTheme>.</clue>
</event>
<event KT="Fact" id="E16">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="T33"/>
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) <clueType>required</clueType> <linkTheme>for</linkTheme> maximal expression of the gene.</clue>
</event>
<event KT="Fact" id="E83">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="T35"/>
<clue>Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) <clueType>required</clueType> <linkTheme>for</linkTheme> maximal expression of the gene.</clue>
</event>
<event KT="Analysis" id="E84">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="E13"/>
<clue>Two <clueType><clueKT>explanations</clueKT></clueType> <linkTheme>for</linkTheme> hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event KT="Analysis" id="E85">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="E81"/>
<clue>Two <clueType><clueKT>explanations</clueKT></clueType> <linkTheme>for</linkTheme> hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event KT="Analysis" id="E86">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="E13"/>
<clue>Two <clueType><clueKT>explanations</clueKT></clueType> <linkTheme>for</linkTheme> hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event KT="Analysis" id="E87">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="E81"/>
<clue>Two <clueType><clueKT>explanations</clueKT></clueType> <linkTheme>for</linkTheme> hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event KT="Analysis" id="E88">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="E14"/>
<clue>Two <clueType><clueKT>explanations</clueKT></clueType> <linkTheme>for</linkTheme> hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event KT="Analysis" id="E89">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="E82"/>
<clue>Two <clueType><clueKT>explanations</clueKT></clueType> <linkTheme>for</linkTheme> hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event KT="Analysis" id="E90">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="E14"/>
<clue>Two <clueType><clueKT>explanations</clueKT></clueType> <linkTheme>for</linkTheme> hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<event KT="Analysis" id="E91">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="E82"/>
<clue>Two <clueType><clueKT>explanations</clueKT></clueType> <linkTheme>for</linkTheme> hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.</clue>
</event>
<sentence id="S5">The importance of resolution of this controversy is that future research in this area should be directed toward the understanding of alternative mechanisms that can result in the successful production of <term id="T38" lex="NO" sem="Inorganic_compound">NO</term>.</sentence>
<event KT="Other" id="E21">
<type class="Positive_regulation"/>
<theme idref="T38"/>
<clue>The importance of resolution of this controversy is that future research in this area should be directed toward the understanding of alternative mechanisms that can result in the successful <clueType>production</clueType> <linkTheme>of</linkTheme> NO.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
